These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10215212)

  • 21. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery.
    van der Kamp KW; van Oeveren W
    Int J Artif Organs; 1993 Dec; 16(12):836-42. PubMed ID: 8175200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation as an acute effect of cigarette smoking.
    Kimura S; Nishinaga M; Ozawa T; Shimada K
    Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization.
    Kumano H; Suehiro S; Hattori K; Shibata T; Sasaki Y; Hosono M; Kinoshita H
    Ann Thorac Surg; 1999 Oct; 68(4):1252-6. PubMed ID: 10543488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of coagulation and fibrinolysis during cardiothoracic operations.
    Hunt BJ; Parratt RN; Segal HC; Sheikh S; Kallis P; Yacoub M
    Ann Thorac Surg; 1998 Mar; 65(3):712-8. PubMed ID: 9527200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafamostat mesilate reduces blood cell adhesion to cardiopulmonary bypass circuits: an in-vitro study.
    Hiroura M; Usui A; Kawamura M; Hibi M; Iwase J
    J Extra Corpor Technol; 1994 Sep; 26(3):121-5. PubMed ID: 10150679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients.
    Holloway DS; Summaria L; Sandesara J; Vagher JP; Alexander JC; Caprini JA
    Thromb Haemost; 1988 Feb; 59(1):62-7. PubMed ID: 2452492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative evaluation of the effect of pump type and heparin-coated surfaces on platelets during cardiopulmonary bypass.
    Misoph M; Babin-Ebell J; Schwender S
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):302-6. PubMed ID: 9477463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery.
    Defraigne JO; Pincemail J; Dekoster G; Larbuisson R; Dujardin M; Blaffart F; David JL; Limet R
    Ann Thorac Surg; 2000 Dec; 70(6):2075-81. PubMed ID: 11156123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
    te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
    J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
    Usui A; Hiroura M; Kawamura M; Hibi M; Yoshida K; Murakami F; Tomita Y; Ooshima H; Murase M
    Ann Thorac Surg; 1996 Nov; 62(5):1404-11. PubMed ID: 8893576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
    Valen G; Eriksson E; Risberg B; Vaage J
    Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery.
    Nakahira A; Sasaki Y; Hirai H; Matsuo M; Morisaki A; Suehiro S; Shibata T
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1289-97. PubMed ID: 20800241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.